Importance of Drug Formulation on the Pharmacokinetics of 13-CIS-Retinoic Acid (Isotretinoin) in Children with High-Risk Neuroblastoma

Munzer C.; Concordet D.; Rubie H.; Gambart M.; Defachelles A. S.; Schleiermacher G.; Veal G. J.

首页> 外文期刊>Pediatric blood & cancer >Importance of Drug Formulation on the Pharmacokinetics of 13-CIS-Retinoic Acid (Isotretinoin) in Children with High-Risk Neuroblastoma

【24h】

Importance of Drug Formulation on the Pharmacokinetics of 13-CIS-Retinoic Acid (Isotretinoin) in Children with High-Risk Neuroblastoma

机译：药物制剂对高危神经母细胞瘤儿童13-顺式维甲酸（isotretino）的药代动力学的重要性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2019年第s4期|共2页
作者
Munzer C.; Concordet D.; Rubie H.; Gambart M.; Defachelles A. S.; Schleiermacher G.; Veal G. J.;
展开▼
作者单位

CHU Toulouse Hop Enfants Unite Hematoimmunooncol Toulouse France;

INRA ENVT Umr 181 Toulouse France;

CHU Toulouse Hop Enfants Unite Hematoimmunooncol Toulouse France;

CHU Toulouse Hop Enfants Unite Hematoimmunooncol Toulouse France;

CLCC Oscar Lambret Unite Oncol Pediat Lille France;

Inst Curie Pediat Paris France;

Newcastle Univ Northern Inst Canc Res Newcastle Upon Tyne Tyne &

Wear England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. Importance of Drug Formulation on the Pharmacokinetics of 13-CIS-Retinoic Acid (Isotretinoin) in Children with High-Risk Neuroblastoma [J] . Munzer C., Concordet D., Rubie H., Pediatric blood & cancer . 2019,第S4期

机译：药物制剂对高危神经母细胞瘤儿童13-顺式维甲酸（isotretino）的药代动力学的重要性
2. Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma [J] . VealG.J., ErringtonJ., RowbothamS.E., Clinical cancer research: an official journal of the American Association for Cancer Research . 2013,第2期

机译：适应性给药方法可单独治疗高危神经母细胞瘤儿童的13-顺-视黄酸（异维A酸）
3. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: A Children's Oncology Group study (Journal of Clinical Oncology (2009) 27 (1007-1013)) [J] . Matthay Journal of Clinical Oncology . 2014,第17期

机译：在儿童随机对照试验中进行的一项随机试验：清髓性疗法随后接受13-顺-视黄酸治疗高危神经母细胞瘤的儿童的长期结果：儿童肿瘤学小组研究（临床肿瘤学杂志（2009）27（1007-1013））
4. PD/PK Characterization of Drug Release From Nanoparticles Independent of Formulation: Acute Pharmacokinetics and Cardiovascular Effects of Intravenous Nifedipine [C] . Vrbanac JJ, Humphrey SJ, Buhl AE, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2009

机译：纳米颗粒的Pd / PK表征药物释放独立于制剂：静脉注射氮素的急性药代动力学和心血管作用
5. 1. Pharmacokinetic modeling and simulations of gastrointestinal transit effects on drug pharmacokinetics from enteric-coated pellet formulations and their applications. 2. Development of crushable enteric-coated formulations. 3. Development of leaky enteric-coated pellets formulations. [D] . Watanalumlerd, Prapoch. 2004

机译：1.胃肠道转运对肠溶微丸制剂中药物药代动力学的影响的药代动力学建模和模拟及其应用。 2.开发可压碎的肠溶衣制剂。 3.开发泄漏的肠溶丸剂。
6. Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma – a study of the United Kingdom Childrens Cancer Study Group [O] . G J Veal, M Cole, J Errington, 2007

机译：高危神经母细胞瘤儿童中13-顺-视黄酸（异维A酸）的药代动力学和代谢-英国儿童癌症研究小组的研究
7. Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma – a study of the United Kingdom Children's Cancer Study Group [O] . Veal, G J, Cole, M, Errington, J, 2007

机译：高危神经母细胞瘤儿童中13-顺-视黄酸（异维A酸）的药代动力学和代谢-英国儿童癌症研究小组的研究

Importance of Drug Formulation on the Pharmacokinetics of 13-CIS-Retinoic Acid (Isotretinoin) in Children with High-Risk Neuroblastoma

著录项

引文网络

相似文献

相关主题

期刊订阅